Mesalamine 375 mg/1

Mesalamine 375 mg extended-release capsules are designed to deliver anti-inflammatory effects for gastrointestinal conditions. This medication is commonly used to manage symptoms associated with ulcerative colitis and other inflammatory bowel diseases.

Mesalamine is primarily used for the treatment of inflammatory bowel diseases, such as ulcerative colitis. It works by reducing inflammation in the colon and rectum. Mesalamine 375 mg extended-release capsules are designed to release the medication gradually, providing sustained relief. This medication is often prescribed to maintain remission and manage symptoms associated with these conditions.

Mesalamine may cause common side effects such as nausea, vomiting, and stomach pain. Some users may experience headaches, diarrhea, or mild skin rashes. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Mesalamine should be handled with care, especially for individuals with known allergies to salicylates or other ingredients in the formulation. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any pre-existing conditions or other medications they are taking.

Mesalamine may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other gastrointestinal treatments. Alcohol consumption should be moderated, as it may exacerbate side effects. Always consult a healthcare provider before combining mesalamine with other medications.